GDP: Questions & Answers about the Scope of the EU-GDP Guidelines
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The European GDP Association has recently updated its "Good Distribution Practices (GDP) - FAQs". In this second set of questions and answers, details about the scope are addressed. The following ambiguities are clarified:
Do the EU-GDP Guidelines apply for:
- Veterinary products?
- Investigational Medicinal Products (IMPs)?
- Active Pharmaceutical Products (APIs) and Excipients?
- Hubs?
But the issuance of official GDP certificates is also explained. It is pointed out that "transport companies do not need to hold a wholesale distribution authorisation to transport medicinal products". But, of course, they need to "follow the parts of the GDP guideline relevant to their activities, amongst others Chapter 9". EU competent supervisory authorities carry out GDP inspections (and issue GDP certificates) only of companies holding wholesale distribution authorisations or companies which are aiming for one. Some are also part of GMP inspections at pharmaceutical manufacturers.
Find out more in the FAQs on the European GDP Association website.
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


